-
Annual General Meeting
Progress on Medkalp Pharma India Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
-
Director Appointment
The activity Manish Pandey was appointed as a Director was appointed as a Director on 07 Sep 2024 & has been associated with this company since 1 year 4 months . was completed.
-
Director Appointment
Progress on Syed Rasheed Ali was appointed as a Director was appointed as a Director on 09 Jul 2024 & has been associated with this company since 1 year 6 months . was documented.
-
Director Appointment
Progress on Swati Prajapati was appointed as a Director was appointed as a Director on 09 Jul 2024 & has been associated with this company since 1 year 6 months . was documented.
-
Balance Sheet
The activity Medkalp Pharma India Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
-
Company Incorporation
The activity Medkalp Pharma India Limited was registered on 24 Feb 2018 with Roc Delhi & aged 7 years 10 months as per MCA records. was completed.
Medkalp Pharma India Limited - Company Profile
Medkalp Pharma India Limited, a active public limited company, was established on 24 February 2018 in New Delhi, Delhi, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U74999DL2018PLC329942. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Syed Rasheed Ali (Director), Swati Prajapati (Director), Manish Pandey (Director). Past directors included Paras Gemini, Kishore Kumar Gemini, Vishal Singh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Satender Singh Rawat J-95 Arpan Vihar, Jaitpur Extn., Badarpur, New Delhi, Delhi, 110044.
Company Details
- CIN/LLPIN
U74999DL2018PLC329942
- Registration Number
329942
- Incorporation Date
24 February 2018
- Authorized Capital
₹0.50 M
- Paid-Up Capital
₹0.10 M
- ROC Code
Roc Delhi
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
Medkalp Pharma India Limited
Company Report FY 2025-2026Comprehensive Company Insights
Explore comprehensive insights into Medkalp Pharma India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Syed Rasheed Ali | Director | 09 Jul 2024 | Current |
| Swati Prajapati | Director | 09 Jul 2024 | Current |
| Manish Pandey | Director | 07 Sep 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Sep 2024 | Past |
| Pramod Abcsdd | Director | 28 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 07 Sep 2024 | Past |
| Pramod Abcsdd | Director | 05 Dec 2022 | Past |
| Pramod Abcsdd | Director | 04 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
Unlock access to Medkalp Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
Unlock and access historical data on people associated with Medkalp Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Medkalp Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medkalp Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Medkalp Pharma India Limited?
The CIN of Medkalp Pharma India Limited is U74999DL2018PLC329942.
Where is Medkalp Pharma India Limited headquartered?
Medkalp Pharma India Limited is headquartered at Satender Singh Rawat J-95 Arpan Vihar, Jaitpur Extn., Badarpur, New Delhi, Delhi, 110044.
When was Medkalp Pharma India Limited incorporated?
Medkalp Pharma India Limited was incorporated on 24 February 2018.
Who are the current directors of Medkalp Pharma India Limited?
The current directors of Medkalp Pharma India Limited are
What is the primary industry of Medkalp Pharma India Limited?
The primary industry of Medkalp Pharma India Limited is Hospital And Medical Care.
Is Medkalp Pharma India Limited a listed company?
Medkalp Pharma India Limited is unlisted.
What is the capital structure of Medkalp Pharma India Limited?
The authorized capital of Medkalp Pharma India Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
+91-XXXXXXXXXX